Keep the momentum...., page-2

I think that is the key now Boston. There are a few things in the pipeline that can build momentum in the share price to new highs.
1. GMP certification- must be close
2. Cannepil- full production
3. Increase revenue from derma line - I’m not holding my breath for a earth shattering result but we certainly need to see revenues increase
4. Revenue begin from nutraceuticals line. Again nothing earth shattering but a start. I have more faith in this part of the business
5. And of course Korea....
I note that thrown into a lot of the announcements and documentation from mxc is hints about oncology. With their partnership with RMIT I hope that we hear something soon. Pain relief product focussed on the cancer market? Now that would build some momentum...DYOR IMO